- Home
- RFL vs MNOV Comparison
RFL vs MNOV Comparison
Compare RFL & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFL
- MNOV
- Stock Information
- Founded
- RFL 2017
- MNOV 2000
- Country
- RFL United States
- MNOV United States
- Employees
- RFL N/A
- MNOV N/A
- Industry
- RFL Real Estate
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- RFL Finance
- MNOV Health Care
- Exchange
- RFL Nasdaq
- MNOV Nasdaq
- Market Cap
- RFL 74.4M
- MNOV 68.2M
- IPO Year
- RFL N/A
- MNOV 2005
- Fundamental
- Price
- RFL $1.85
- MNOV $1.34
- Analyst Decision
- RFL
- MNOV Strong Buy
- Analyst Count
- RFL 0
- MNOV 2
- Target Price
- RFL N/A
- MNOV $7.00
- AVG Volume (30 Days)
- RFL 202.8K
- MNOV 48.4K
- Earning Date
- RFL 06-11-2025
- MNOV 08-07-2025
- Dividend Yield
- RFL N/A
- MNOV N/A
- EPS Growth
- RFL N/A
- MNOV N/A
- EPS
- RFL N/A
- MNOV N/A
- Revenue
- RFL $732,000.00
- MNOV N/A
- Revenue This Year
- RFL N/A
- MNOV N/A
- Revenue Next Year
- RFL N/A
- MNOV N/A
- P/E Ratio
- RFL N/A
- MNOV N/A
- Revenue Growth
- RFL 35.56
- MNOV N/A
- 52 Week Low
- RFL $1.28
- MNOV $1.12
- 52 Week High
- RFL $3.19
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- RFL 44.17
- MNOV 54.24
- Support Level
- RFL $2.03
- MNOV $1.31
- Resistance Level
- RFL $2.16
- MNOV $1.50
- Average True Range (ATR)
- RFL 0.14
- MNOV 0.06
- MACD
- RFL -0.04
- MNOV 0.02
- Stochastic Oscillator
- RFL 6.06
- MNOV 48.28
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.